Dr. Maron is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
77 Avenue Louis Pasteur
Boston, MA 02115Phone+1 617-525-4803
Education & Training
Brigham and Women's HospitalFellowship, Cardiovascular Disease, 2008 - 2011
Boston University Medical CenterResidency, Internal Medicine, 2003 - 2005
The Warren Alpert Medical School of Brown UniversityClass of 2003
Certifications & Licensure
MA State Medical License 2006 - 2025
MD State Medical License 2023 - 2025
NH State Medical License 2024 - 2024- American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study Start of enrollment: 2015 Sep 01
- Pulmonary Hemodynamics During Exercise - Research Network Start of enrollment: 2018 Dec 01
Roles: Contact
Publications & Presentations
PubMed
- 39 citationsTranslational Advances in the Field of Pulmonary Hypertension.Focusing on Developmental Origins and Disease Inception for the Prevention of Pulmonary HypertensionBradley A. Maron, Steven H. Abman
American Journal of Respiratory and Critical Care Medicine. 2017-02-01 - 20 citationsPulmonary Hypertension: A Contemporary Review.Shelsey Johnson, Natascha Sommer, Katherine Cox-Flaherty, Norbert Weissmann, Corey E Ventetuolo
American Journal of Respiratory and Critical Care Medicine. 2023-09-01 - 458 citationsGenetic Misdiagnoses and the Potential for Health DisparitiesArjun K. Manrai, Birgit Funke, Heidi L. Rehm, Morten S. Olesen, Bradley A. Maron
The New England Journal of Medicine. 2016-08-17
Lectures
- A Panoply of Perspectives on Pulmonary Hypertension: Patients Practitioners and Political Advocates2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
- Co-Moderator: Plain Spoken Perspectives on Pulmonary Hypertension2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
- Addition of Spironolactone to Ambrisentan May Be a Novel Treatment Strategy to Improve Outcome in Patients With PAH2013 International Conference, Philadelphia, Pennsylvania, USA
- Join now to see all
Press Mentions
Maron Will Co-Direct Institute for Health ComputingMay 3rd, 2023- New Approach Can Help Treat Hypertrophic Cardiomyopathy with Precision MedicineFebruary 25th, 2021
- Study Sheds Wider Light on the Clinical Profile of Patients with Pulmonary HypertensionJuly 28th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
